Senores Pharmaceuticals Limited · NSE: SENORES · BSE: 544319
Senores Pharmaceuticals
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 27 Jul 2026.
Q1 FY27 · Consolidated
Revenue
180.21₹ Cr
+30.6% vs year ago
Net profit
30.45₹ Cr
+43.8% vs year ago
EPS, basic
6.61₹
+43.7% vs year ago
Net margin
16.9%
+1.5 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 180.21 | +30.6% | 30.45 | +43.8% | 6.61 | 27 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 175.19 | +53.4% | 36.67 | +104.1% | 7.96 | 14 May 2026 |
| Q3 FY26Oct–Dec 2025 | 174.56 | +69.4% | 33.58 | +104.4% | 7.29 | 20 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 161.76 | — | 30.12 | — | 6.54 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 137.99 | — | 21.18 | — | 4.60 | 25 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 114.21 | — | 17.97 | — | 3.81 | 15 May 2025 |
| Q3 FY25Oct–Dec 2024 | 103.02 | — | 16.43 | — | 5.04 | 24 Jan 2025 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 26.99 | +36.2% | 1.03 | −61.9% | 0.22 | 27 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 36.81 | +210.4% | 8.48 | +319.8% | 1.84 | 14 May 2026 |
| Q3 FY26Oct–Dec 2025 | 28.76 | +199.9% | 2.65 | +146.5% | 1.98 | 20 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 35.33 | — | 6.43 | — | 1.40 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 19.82 | — | 2.70 | — | 0.59 | 25 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 11.86 | — | 2.02 | — | 0.39 | 15 May 2025 |
| Q3 FY25Oct–Dec 2024 | 9.59 | — | 1.07 | — | 0.32 | 24 Jan 2025 |
14 filings on record for this company.